Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC - Forrer, F; Uusijärvi, H; Storch, D; Maecke, H R; Mueller-Brand, J (J Nucl Med, 2005)